Altered pattern of cytokine production by peripheral blood CD2+ cells from B chronic lymphocytic leukemia patients

American Journal of Hematology

Volumn 57, Issue 2, 1998, Pages 93-100

  Reyes, Eduarde ^a   Prieto, Alfredo ^a   Carrión, Flavio ^a   García Suarez, Julio ^b   Esquivel, Fatima ^a   Guillén, Cristina ^a   Alvarez Mon, Melchor ^a,b  

^a UNIVERSITY OF ALCALÁ   (Spain)

^b HOSPITAL UNIVERSITARIO PRÍNCIPE DE ASTURIAS   (Spain)

Author keywords

B chronic lymphocytic leukemia; Interferon; Interleukin; Smouldering B CLL; Tumor necrosis factor

Indexed keywords

CD2 ANTIGEN; CD3 ANTIGEN; CD45 ANTIGEN; CD56 ANTIGEN; GAMMA INTERFERON; INTERLEUKIN 2; INTERLEUKIN 4; LYMPHOTOXIN; MONOCLONAL ANTIBODY; TUMOR NECROSIS FACTOR ALPHA;

ADULT; AGED; ANTIGEN EXPRESSION; APOPTOSIS; ARTICLE; B LYMPHOCYTE; CANCER STAGING; CANCER SURVIVAL; CELL PROLIFERATION; CHRONIC LYMPHATIC LEUKEMIA; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED STUDY; CYTOKINE PRODUCTION; DISEASE COURSE; FEMALE; HUMAN; IMMUNOSTIMULATION; LYMPHOCYTE ACTIVATION; MALE; PATHOGENESIS; PRIORITY JOURNAL; T LYMPHOCYTE SUBPOPULATION;

ADULT; AGED; AGED, 80 AND OVER; ANTIGENS, CD2; CYTOKINES; FEMALE; HUMANS; LEUKEMIA, B-CELL, CHRONIC; LYMPHOCYTES; MALE; MIDDLE AGED;

EID: 0031907698     PISSN: 03618609     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1096-8652(199802)57:2<93::AID-AJH1>3.0.CO;2-W     Document Type: Article

References (50)

1. Galton DAG: The pathogenesis of chronic lymphocytic leukemia. Can Med Assoc J 94:1005, 1966.
2. Damesheck W: Chronic lymphocytic leukemia-an accumulative disease of immunologically incompetent lymphocytes. Blood 29:566, 1967.
3. Caligaris-Cappio F, Gobbi M, Bofill M, Janossy G: Infrequent normal B lymphocytes express features of B-chronic lymphocytic leukemia. J Exp Med 155:623, 1982.
4. Bennett JM, Catovsky D, Daniel M-T, Flandrin G, Gallon DAG, Gralnick HR, Sultan C: The French-American-British (FAB) Cooperative Group proposals for the classification of chronic (mature) B and T lymphoid leukaemias. J Clin Pathol 42:567, 1989.
5. Boogs DR, Sofferman SA, Wintrobe MM, Cartwright GE: Factors influencing the duration of survival of patients with chronic lyphocytic leukemia. Am J Med 40:243, 1966.
6. Catovsky D, Miliani E, Okos A, Galton D: Clinical significance of T cells in chronic lymphocytic leukaemia. Lancet 2:751, 1974.
7. Davis S: Characterization of the phytohemagglutinin-induced proliferating lymphocyte subpopulations in chronic lymphocytic leukemia patients using a clonogenic agar technique and monoclonal antibodies. Blood 58:1053, 1981.
8. Plastsoucas CD, Galinski M, Kempin S, Reicm L, Clarkson B, Good RA: Abnormal T lymphocyte subpopulations in patients with B cell chronic lymphocytic leukemia: An analysis by monoclonal antibodies. J Immunol 129:2305, 1982.
9. Lauria F, Foa R, Montavani V, Fierro T, Catovsky D, Tura S: T-cell functional abnormality in B-chronic lymphocytic leukaemia: Evidence for a defect in the T-helper subset. Br J Haematol 54:277, 1983.
10. Semenzato G, Pezzutto A, Foa R, Lauria F, Raimondi R: T lymphocytes in B-cell chronic lymphocytic leukemia: characterization by monoclonal antibodies and correlation with Fc receptors. Clin Immunol Immunopathol 26:155, 1983.
11. Kay NE, Kaplan ME: Defective expression of T cell antigens in chronic lymphocytic leukaemia: Relationship to T cell dysfunction. Br J Haematol 57:105, 1984.
12. Alvarez de Mon M, Casas J, Laguna R, Toribio ML, de Landázury MO. Durantez A: Lymphokine induction of NK-like cytotoxicity in T cells from B-CLL. Blood 67:228, 1986.
13. Totterman TH, Carlsson M, Simonsson B, Bengtsson M, Nilsson K: T-cell activation and subset patterns are altered in B-CLL and correlate with the stage of the disease. Blood 74:786, 1989.
14. Herrmaun F, Lochner A, Philippen H, Jauer B, Ruhl H: Imbalance of T cell subpopulations in patients with chronic lymphocytic leukemia of the B cell type. Clin Exp Immunol 49:157, 1982.
15. Peller S, Kaufman S: Decreased CD45RA T cells in B-cell chronic lymphatic leukemia patients: Correlation with disease stage. Blood 78:1569, 1991.
16. Vuillier F, Tortevoye P, Binet JL, Dighiero G: CD4, CD8 and NK subsets in B-CLL. Nouv Rev Fr Hematol 30:331, 1988.
17. Dianzani U, Omedè P, Marmont F, DiFranco D, Fusaro A, Bregardo M, Redoglia V, Giaretta F, Mairone L, Boccadore M, Resegotti, Pileri A: Expansion of T cells expressing low CD4 or CD8 levels in B-cell chronic lymphocytic leukemia: Correlation with disease status and neoplastic phenotype. Blood 83:2198, 1994.
18. Briggs PG, Kraft N, Atkins RC: T cells and CD45R expression in B-chronic lymphocytic leukemia. Leuk Res 14:155, 1990.
19. Peller S, Kaufman S: Decreased CD45RA T cells in B-cell chronic lymphatic leukemia patients: Correlation with disease stage. Blood 78:1569, 1991.
20. Garcia-Suarez J, Prieto A, Reyes E, Merino JL, Alvarez-Mon M: Increased percentage of activated T lymphocytes in B-cell chronic lymphocytic leukaemia (B-CLL) patients. Br J Haematol 79:657, 1991.
21. Kay EN: Abnormal T-cell subpopulation function in CLL: Excessive suppressor (Tγ) and deficient helper (Tμ) activity with respect to B-cell proliferation. Blood 57:418, 1981.
22. Prieto A, Garcia-Suarez J, Reyes E, Lapena P, Merino JL, Alvarez-Mon M: Diminished DNA synthesis in T cells from B chronic lymphocytic leukemia after surface and intracytoplasmatic mitogenic signals. Exp Haematol 21:1563, 1993.
23. Alvarez-Mon M, García-Suarez J, Prieto A, Manzano L, Reyes E, Lorences C, Peraile G, Jorda J, Durantez A: Heterogeneus proliferative effect of tumor necrosis factor-α and lymphotoxin on mitogen-activated B cells from B-cell chronic lymphocytic leukemia. Am J Hematol 43:81, 1993.
24. Fernandez RC, Lee SH, Fernandez LA, Pope BL, Rozee KR: Production of alpha-interferon by peripheral blood mononuclear cells from normal individuals and patients with chronic lymphocytic leukemia. J Interferon Res 6:573, 1986.
25. Rossi JF, Klein B, Commes T, Jourdan M: Interleukin 2 production in B cell chronic lymphocytic leukemia. Blood 66:840, 1985.
26. Buschle M, Campana D, Carding SR, Richard C, Hoffbrand AV, Brenner MK: IFN-gamma inhibits programmed cell death and promotes survival of B-CLL cells in culture. J Exp Med 177:213, 1993.
27. Foa R, Massaia M, Cardona S, Gillio Tos A, Bianchi A, Attisano C, Guarini A, Francia di Celle P, Fierro MT: Production of tumor necrosis factor-alpha by B-cell chronic lymphocytic leukemia cells: A possible regulatory role of TNF-α in the progression of the disease. Blood 76:393, 1990.
28. van Kooten C, Rensink I, Aarden L, van Oers R: Interleukin-4 inhibits both paracrine and autocrine tumor necrosis factor-alpha-induced proliferation of B chronic lymphocytic leukemia cells. Blood 80:1299, 1992.
29. Aderka D, Maor Y, Novic D, Engelmann H, Khan Y, Levo Y, Wallack D, Revel M: Interleukin-6 inhibits the proliferation of B chronic lymphocytic leukemia cells that is induced by tumor necrosis factor-alpha or beta. Blood 81:2076, 1993.
30. Lotz M, Ranheim E, Kipps TJ: Transforming growth factor beta as endogenous growth inhibitor of chronic lymphocytic leukemia B cells. J Exp Med 179:999, 1994.
31. Huang RW, Tsuda H, Takatsuki K: Interleukin-2 prevents programmed cell death in chronic lymphocytic leukemia cells. Int J Hematol 58:83, 1993.
32. Dancescu M, Rubio-Trujillo M, Biron G, Bron D, Delepesse G, Sarfati S: Interleukin 4 protects chronic lymphocytic leukemic B cells from death by apoptosis and upregulates Bcl-2 expression. J Exp Med 176:1319, 1992.
33. Panayiotidis P, Ganeshagaru K, Jabbar SA, Hoffbrand AV: Interleukin-4 inhibits apoptotic cell death and loss of the bcl-2 protein in B-chronic lymphocytic leukaemia cells in vitro. Br J Haematol 85:439, 1993.
34. Fluckiger AC, Durand I, Banchereau J: Interleukin 10 induces apoptotic cell death of B-chronic lymphocytic leukemia cells: J Exp Med 179:91, 1994.
35. International Workshop on Chronic Lymphocytic Leukemia: Chronic lymphocytic leukemia: Recommendations for diagnosis, staging, and response criteria. Ann Intern Med 110:236, 1989.
36. Binet JL, Auquier A, Dighiero G, Chastang C, Piguet H, Goasguen J, Vaugier G, Potron G, Colona P, Oberling F, Thomas M, Tchernia G, Jacquillat C, Boivin P, Lesty C, Duault MT, Monconduit M, Beiabbes S, Gremy F: A new prognostic classification of chronic lymphocytic leukemia derived from a multivariate survival analysis. Cancer 48:198, 1981.
37. Monserrat E, Vinolas L, Reverter JC. Rozman C: Natural history of chronic leukemia: on the progression and prognosis of early clinical stages. Nouv Rev Fr Haematol 30:359, 1988.
38. Pistoia V, Cozzolino F, Rubartelli A, Torcia M, Roncella S, Ferrarini M: In vitro production of interleukin 1 by normal and malignant human B lymphocytes. J Immunol 136:1688, 1986.
39. Cordingley FT, Bianchi A, Hoffbrand AV, Reittie JE, Heslop HE, Vyakarman A, Turner Maeger A, Bremer MK: Tumor necrosis factor as an autocrine tumor growth factor for chronic B-cell malignancies. Lancet 1:969, 1988.
40. Biondi A, Rossi V, Bassan R, Barbui T, Bettoni S, Sironi M, Mantovani A, Rambaldi A: Constitutive expression of the interleukin-6 gene in chronic lymphocytic leukemia Blood 73:1279, 1989.
41. Dadmarz R, Rabinobe SN, Canistra SA, Andersen JW, Freedman AS, Nadler LM: Association between clonogenic cell growth and clinical risk group in B-cell chronic lymphocytic leukemia. Blood 76:142, 1990.
42. Ehlers S, Kendall AS: Differentiation of T cell Lymphokine gene expression: The in vitro acquisition of T cell memory. J Exp Med 173:25, 1991.
43. Adamthwaite A, Cooley MA: CD8+ T-cell subsets defined by expression of CD45 isoforms differ in their capacity to produce IL-2, IFN-γ and TNF-β. Immunology 81:253, 1994.
44. Jong R, Brower M, Miedema F, Van Lier RAW: Human CD8+ T lymphocytes can be divided into CD45RA+ and CD45RO+ cells with different requirements for activation and differentiation. J Immunol 146:2088, 1991.
45. Farace F, Orlanducci F, Dietrich PY, Gaudin C, Angevin E, Courtier MH, Bayle C, Hercend T, Triebel F: T cell repertoire in patients with B chronic lymphocytic leukemia: Evidence for multiple in vivo T cell clonal expansions. J Immunol 153:4281, 1994.
46. Decker T, Flohr T, Trautmann P, Aman J, Holter W, Majdic O, Huber C, Peschel C: Role of accessory cells in cytokine production by T cells in chronic B-cell lymphocytic leukemia. Blood 86:1115, 1995.
47. Foa R, Giovarelli M, Jemma C, Fierro MT, Lusso P, Ferrando ML, Lauria F, Forni G: Interleukin 2 (IL-2) and interferon-gamma production by T lymphocytes from patients with B-chronic lymphocytic leukemia: evidence that normally released IL 2 is absorbed by the neoplastic B cell population. Blood 66:614, 1985.
48. Kay NE, Kaplan ME: Defective T cell responsiveness in chronic B-cell lymphocytic leukemia: Analysis of activation events. Blood 67:578, 1986.
49. Nakamura N, Suzuki S, Segami H, Nozawa Y, Tominaga K, Wachi E, Hojo H, Abe M, Sakuma H, Wakasa H: Clinicopathological and immunophenotypic studies on 12 cases with B cell chronic lymphocytic leukemia. Pathol Int 44:779, 1994.
50. Duan X, Nerl C, Janssen O, Kabelitz D: B-cell maturation in chronic lymphocytic leukemia IV. T cell-dependent activation of leukemic cells by Staphylococcal enterotoxin superantigens. Immunology 75:420, 1992.